Company profile

Akero Therapeutics, Inc. Insider Trading

AKRO

Every SEC Form 4 insider trading filing for Akero Therapeutics, Inc. (AKRO) since April 2023 — open-market buys and sells by directors and officers, option exercises, and cluster activity, updated as each filing is reported to the SEC. Why 2023?

Sector
Pharmaceutical Preparations
CIK
0001744659
Filings
230
Insiders
14
Last filing
2025-12-09

Activity summary

No insider transactions in the last 30 days. The most recent was on December 9, 2025, when White William Richard sold 2,328 shares. 230 filings from 14 insiders are on record below.

Three year balance

Buy and sell value by quarter, Q3 22 to Q4 25. Akero Therapeutics, Inc. insiders are net sellers across the period shown.

Q3 22Q2 23Q3 23Q4 23Q1 24Q2 24Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25

Bars below the rule are sales, above are purchases. Largest quarter on the chart is $22.1M.

No insider activity recorded for AKRO in the last 90 days.

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Dec 9, 2025White William RichardAKRO
Disposition
2,328
Dec 9, 2025White William RichardAKRO
Disposition
3,527
Dec 9, 2025White William RichardAKRO
Disposition
47,573
Dec 9, 2025White William RichardAKRO
Disposition
5,032
Dec 9, 2025White William RichardAKRO
Disposition
4,739

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Query this yourself

The same rows, over the API.

curl "https://api.form4api.com/v1/transactions?ticker=AKRO" \
  -H "X-Api-Key: $KEY"
Get a key